Journal of Jilin University(Medicine Edition) ›› 2021, Vol. 47 ›› Issue (1): 59-65.doi: 10.13481/j.1671-587x.20210108
• Research in basic medicine • Previous Articles Next Articles
Lu LIU1,Tianfu ZHANG1,Xiaofeng WANG1(
),Chenfei KONG2(
)
Received:2020-09-03
Online:2021-01-28
Published:2021-01-27
Contact:
Xiaofeng WANG,Chenfei KONG
E-mail:wangxiaofeng@jlu.edu.cn;kongchenfei@jlu.edu.cn
CLC Number:
Lu LIU,Tianfu ZHANG,Xiaofeng WANG,Chenfei KONG. Regulatory effects of syndecan-1 on migration, invasion and cell cycle of tongue squamous cell carcinoma CAL27 cells[J].Journal of Jilin University(Medicine Edition), 2021, 47(1): 59-65.
| 1 | BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. |
| 2 | TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108. |
| 3 | FELLER L, LEMMER J. Oral squamous cell carcinoma: epidemiology, clinical presentation and treatment[J]. J Cancer Ther, 2012, 3(4): 263-268. |
| 4 | ZHANG H, FU X, SU X,et al. CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis[J]. Exp Ther Med, 2018, 15(5):4271-4276. |
| 5 | KOYFMAN S A, ISMAILA N, HOLSINGER F C. Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline summary[J]. J Oncol Pract, 2019, 15(5): 273-278. |
| 6 | LIAO S Y, LIU C, ZHU G Y, et al. Relationship between SDC1 and cadherin signalling activation in cancer[J]. Pathol Res Pract, 2020, 216(1): 152756. |
| 7 | FARNEDI A, ROSSI S, BERTANI N, et al. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors[J]. BMC Cancer, 2015, 15: 352. |
| 8 | WU Y X, HUANG H T, FERVERS B, et al. Syndecan-1 and KRAS gene expression signature associates with patient survival in pancreatic cancer[J]. Pancreas, 2020, 49(9): 1187-1194. |
| 9 | HUANG X, REYE G, MOMOT K I, et al. Heparanase promotes syndecan-1 expression to mediate fibrillar collagen and mammographic density in human breast tissue cultured ex vivo[J]. Front Cell Dev Biol, 2020, 8:599. |
| 10 | LIN S C, WU C P, TSENG T, et al. Role of syndecan-1 and exogenous heparin in hepatoma sphere formation[J]. Biochem Cell Biol, 2020, 98(2):112-119. |
| 11 | MARTÍNEZ A, SPENCER M L, BRETHAUER U, et al. Reduction of syndecan-1 expression during lip carcinogenesis[J]. J Oral Pathol Med, 2009, 38(7):580-583. |
| 12 | GHANTOUS Y, IABU ELNAAJ. Global incidence and risk factors of oral cancer[J]. Harefuah, 2017, 156(10):645-649. |
| 13 | 王珍珍,杜文治,贾 如,等. 基于生物信息学分析SOX12在口腔鳞状细胞癌中的表达及验证[J]. 西安交通大学学报(医学版),2020,41(1): 64-68 |
| 14 | SZATMÁRI T, ÖTVÖS R, HJERPE A, et al. Syndecan-1 in cancer: implications for cell signaling, differentiation, and prognostication[J]. Dis Markers, 2015, 2015: 796052. |
| 15 | PAP Z, PÁVAI Z, DÉNES L, et al. An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1[J]. Pathol Oncol Res, 2009, 15(4):579-587. |
| 16 | CONTRERAS H R, LEDEZMA R A, VERGARA J, et al. The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer[J]. Urol Oncol, 2010, 28(5):534-540. |
| 17 | WANG X F, HE J T, ZHAO X M, et al. Syndecan-1 suppresses epithelial-mesenchymal transition and migration in human oral cancer cells[J]. Oncol Rep, 2018, 39(4): 1835-1842. |
| 18 | AHMED HAJI OMAR A, HAGLUND C, VIROLAINEN S, et al. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas[J]. J Oral Pathol Med, 2013, 42(5): 389-395. |
| 19 | ARAGÃO A Z, BELLONI M, SIMABUCO F M, et al. Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration[J]. PLoS One, 2012, 7(8):e43521. |
| 20 | ZHANG J F, BU X, WANG H Z, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance[J]. Nature, 2018, 553(7686): 91-95. |
| [1] | Xiao ZHOU,Haitao DAI,Yunshan DING,Linjie ZHANG,Nan WU. Network pharmacology analysis and in vitro experimental validation of anticancer effect of grape seed proanthocyanidins against oral squamous cell carcinoma [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 651-662. |
| [2] | Li ZHAI,Meng CHEN,Jianbo LUO,Aili ZHANG,Liangxiao WANG,Ying WEI,Xi ZHANG. Targeting relationship between miR-214-3p and EZH2 and its effects on proliferation, invasion, and apoptosis of ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 460-468. |
| [3] | Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482. |
| [4] | Yunshan DING,Haitao DAI,Min CHEN,Xiaohui HAO,Xiao ZHOU,Nan WU. Effect of silencing TRPV2 gene and cannabidiol on biological behaviors of oral squamous cell carcinoma CAL-27 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 143-151. |
| [5] | Shanshan SUN,Mei LU,Xinfu GAO,LYu Guangyao,Baolei Zhao,LYu Wenwen. Inhibitory effect of Bradykinin 1 receptor antagonist ELN441958 on proliferation of HepG2 cells by regulating Akt/FoxO3a signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 70-80. |
| [6] | Dayou DAI,Zhigang ZHANG,Hui LI. Effect of CHRNA5 in occurrence and development of pancreas cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1518-1531. |
| [7] | Sifan FENG,Yunfeng LI,Jiaying WANG,Fubin MA,Yan WANG. Effects of heme-binding protein 1 gene knockdown on proliferation, migration, and inflammatory response of microglia BV2 and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1532-1541. |
| [8] | Pingsheng ZHU,Sitang GE,Lugen ZUO,Deli CHEN,Yangyang ZHANG. Effect of miR-325-3p targeting PRELID1 gene in regulation of EMT pathway on invasion and migration of colon cancer cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1185-1193. |
| [9] | Wenxuan LI,Minru ZONG. Research progress in role of migration of Schwann cells in repairment of peripheral nerve injury [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1137-1144. |
| [10] | Zhongjun SHEN,Yao ZHAO,Mingbo JIA,Liyan ZHAO. Research progress in effects of hypoxia-inducible factors on cell migration and invasion during epithelial-mesenchymal transition in glioma cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1145-1154. |
| [11] | Yixuan GAO,Peng WANG,Silong ZHANG,Ruijuan GAO,Yingfang MA,Keke ZHANG,Dan FENG,Zongqi HUANG,Ketao MA,Li LI,Junqiang SI. Inhibitory effect of safranal on proliferation, migration and phenotypic transformation of vascular smooth muscle cells of rats induced by high glucose in vitro [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 948-957. |
| [12] | Hongli LI,Mengyao WANG,Yangyang LIU,Hui ZHANG,Li LI. Effect of KHSRP on biological behavior of colorectal cancer cells through activation of JAK/STAT signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 996-1006. |
| [13] | Donghui LIU,Yunzhe CI,Chunyan WANG,Wenyi MA. Effect of miR-199a-5p on expression of Caveolin-1, cell migration and apoptosis in glioma U251 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 663-671. |
| [14] | Fan WANG,Xin WEN,Yixuan WANG,Yuan WANG. Effect of gap junction β2 on prognosis of patients with lung adenocarcinoma and biological behavior of lung adenocarcinoma A549 cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 716-726. |
| [15] | Yihui WANG,Qing ZHANG,Yingnan LI,Liping YE. Effect of KIAA1522 on proliferation, migration, and invasion of lung cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 727-739. |